Phathom Pharmaceuticals, Inc. (PHAT)
11.39
-0.48
(-4.04%)
USD |
NASDAQ |
May 18, 16:00
11.40
+0.01
(+0.09%)
After-Hours: 20:00
Phathom Pharmaceuticals Research and Development Expense (Quarterly) : 7.771M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 10.60M |
| Ligand Pharmaceuticals, Inc. | 2.148M |
| Axsome Therapeutics, Inc. | 52.56M |
| Corcept Therapeutics, Inc. | 66.26M |
| Assertio Holdings, Inc. | 0.454M |